Metabolic
Tirzepatide
GIP GLP-1 co-agonist / Mounjaro / Zepbound
- Peptide length
- 39 amino acids
Acylated peptide analog
Research contextDefined therapeutic evidence
Read the linked studies for their methods and limitations.
A dual GIP and GLP-1 receptor agonist used in regulated medicines with product-specific indications.
- Family
- Dual incretin agonist
- Research frame
- GIP and GLP-1 receptors
- Molecular format
- Acylated peptide analog
- Formula in linked identity record
- C225H348N48O68
Read the evidence
Distinguish diabetes, weight-management and obstructive-sleep-apnea evidence. Receptor activity alone does not predict comparative clinical outcomes.
Resolve the identity
Check the full modified structure and lipid side chain. A backbone length or purity percentage does not establish pharmaceutical equivalence.